Using MRI to Map Brain Development in Early Childhood

Researchers led by the University of North Carolina have employed advanced functional MRI (fMRI) techniques to create detailed charts tracking brain network maturation from birth to age six. These brain connectivity maps reveal critical developmental transitions in how different regions of the brain interact, providing insights into typical and atypical neural development. The study analyzed over 1,000 resting-state fMRI scans from 501 children across five cohorts, harmonizing data gathered during sleep and wakefulness using machine learning and statistical methods such as elastic net regression and the ComBat technique to account for variability.
The findings highlight significant changes in the strength and interaction of key neural networks, including visual, somatomotor, limbic, default, attention, and control networks. For example, visual and somatomotor connectivity peak early in infancy and decrease as children grow, while networks associated with higher cognitive functions like the default mode and control networks gradually increase, reaching a plateau around 4 to 6 years.
Importantly, deviations from these typical developmental trajectories were linked to differences in cognitive abilities, including language, motor skills, and visual reception. This suggests that brain growth charts could serve as early indicators for identifying children at risk for developmental delays.
The study demonstrates the potential of resting-state fMRI as a tool for monitoring brain development in early childhood, offering a new approach to identify and intervene in atypical cognitive development sooner. Future research aims to refine these charts further by including more awake-state imaging, improving early detection and intervention strategies.
Source: https://medicalxpress.com/news/2025-04-mri-brain-growth-early-childhood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Improved Diagnostic Tool Enhances Global Monitoring of Strongyloidiasis
A new advanced diagnostic test developed by researchers improves the detection and monitoring of strongyloidiasis, a neglected tropical disease, by accurately distinguishing between key parasite species affecting humans and animals.
Ajovy (Fremanezumab) Shows Limited Benefits for Migraine and Depression in Clinical Trial
A recent clinical trial shows that Ajovy (fremanezumab) provides minimal additional benefit over placebo in treating migraine and depression, highlighting the need for more effective therapies.
MRI Detection of Brain Iron Levels as a Predictor of Cognitive Decline
Innovative MRI techniques measuring brain iron levels may predict early cognitive decline, offering a promising tool for early intervention in neurodegenerative diseases like Alzheimer's.



